BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11345831)

  • 1. Clinical perception of disease probability associated with Bethesda System diagnoses.
    Raab SS; Hart AR; D'Antonio JA; Grzybicki DM
    Am J Clin Pathol; 2001 May; 115(5):681-8. PubMed ID: 11345831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical glandular cells--an update.
    Cangiarella JF; Chhieng DC
    Diagn Cytopathol; 2003 Nov; 29(5):271-9. PubMed ID: 14595795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver variability in cytologic subclassification of squamous intraepithelial lesions--the Bethesda System vs. World Health Organization classification.
    Pajtler M; Audy-Jurković S; Milicić-Juhas V; Staklenac B; Pauzar B
    Coll Antropol; 2006 Mar; 30(1):137-42. PubMed ID: 16617588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician attitudes toward the Bethesda System of reporting cervical cytology.
    Ferris DG; Miller MD; Wagner P; Walaitis E
    Fam Pract Res J; 1993 Sep; 13(3):267-73. PubMed ID: 8296590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bethesda system for cervical/vaginal cytologic diagnoses.
    Herbst AL
    Clin Obstet Gynecol; 1992 Mar; 35(1):22-7. PubMed ID: 1544245
    [No Abstract]   [Full Text] [Related]  

  • 6. The Pap smear.
    Colyar MR
    Adv Nurse Pract; 2002 Jul; 10(7):22. PubMed ID: 12420546
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
    Chacho MS; Mattie ME; Schwartz PE
    Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma.
    Jarboe EA; Liaw KL; Thompson LC; Heinz DE; Baker PL; McGregor JA; Dunn T; Woods JE; Shroyer KR
    Oncogene; 2002 Jan; 21(4):664-73. PubMed ID: 11850794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the evaluation and treatment of cervical dysplasia by gynecologists and nurse practitioners.
    Morris DL; McLean CH; Bishop SL; Harlow KC
    Nurse Pract; 1998 Apr; 23(4):101-2, 108-10, 113-4. PubMed ID: 9579352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BSCC, Bethesda or other? Terminology in cervical cytology European panel discussion.
    Kocjan G; Priollet BC; Desai M; Koutselini H; Mahovlic V; Oliveira MH; Pohar-Marinsek Z; Sauer T; Schenk U; Shabalova I; Herbert A
    Cytopathology; 2005 Jun; 16(3):113-9. PubMed ID: 15924605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting.
    Dulai GS; Farmer MM; Ganz PA; Bernaards CA; Qi K; Dietrich AJ; Bastani R; Belman MJ; Kahn KL
    Cancer; 2004 May; 100(9):1843-52. PubMed ID: 15112264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and management of the AGUS Papanicolaou smear.
    Kaferle JE; Malouin JM
    Am Fam Physician; 2001 Jun; 63(11):2239-44. PubMed ID: 11417776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Papanicolaou test quality and reducing medical errors by using Toyota production system methods.
    Raab SS; Andrew-Jaja C; Condel JL; Dabbs DJ
    Am J Obstet Gynecol; 2006 Jan; 194(1):57-64. PubMed ID: 16389010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pale dyskaryosis in cervical smears.
    McKee G
    Cytopathology; 1997 Feb; 8(1):68. PubMed ID: 9068962
    [No Abstract]   [Full Text] [Related]  

  • 15. Telecytology: intraobserver and interobserver reproducibility in the diagnosis of cervical-vaginal smears.
    Alli PM; Ollayos CW; Thompson LD; Kapadia I; Butler DR; Williams BH; Rosenthal DL; O'leary TJ
    Hum Pathol; 2001 Dec; 32(12):1318-22. PubMed ID: 11774163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of false-positive diagnoses in vaginal smears with the Papanicolaou method. (Some non-cancerous lesions of the uterine cervix appear with cytological aspects which may lead to positive or suspicious diagnoses)].
    CAPPA AP
    Pathologica; 1961; 53():1-26. PubMed ID: 13690598
    [No Abstract]   [Full Text] [Related]  

  • 17. The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?
    Pretorius RG; Belinson JL; Zhang WH; Burchette RJ; Elson P; Qiao YL
    J Reprod Med; 2001 Aug; 46(8):724-8. PubMed ID: 11547646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-positive squamous cell carcinoma in cervical smears: cytologic-histologic correlation in 19 cases.
    Levine PH; Elgert PA; Mittal K
    Diagn Cytopathol; 2003 Jan; 28(1):23-7. PubMed ID: 12508178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inadequate screening in patients evaluated by nongynecologists for cervical cancer: a case control analysis.
    Cole ME; Milam MR; Scott TA; Jones HW
    Am J Obstet Gynecol; 2008 May; 198(5):e48-50. PubMed ID: 18342826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bethesda System for reporting cervical and vaginal cytologic diagnoses: report of the 1991 Bethesda workshop.
    J Fam Pract; 1992 Jul; 35(1):98-101. PubMed ID: 1613480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.